Integrative genetic analyses for drug repurposing identify emodin as a candidate modulator of STAT3 signaling in abdominal aortic aneurysm.
Emodin is identified as a candidate modulator of AAA progression acting through suppression of STAT3-associated signaling pathways, and the potential of genetic evidence-guided drug repurposing strategies in complex vascular diseases is demonstrated.